ICF & HIPAA waivers Human Subject Protection Office UConn Health Center Monika Haugstetter, MHA, RN, MSN & HSPO/IRB Staff.

Slides:



Advertisements
Similar presentations
The Role of the IRB An Institutional Review Board (IRB) is a review committee established to help protect the rights and welfare of human research subjects.
Advertisements

Human Subject Protection Office UConn Health Center
Open Library June 4, 2004 Informed Consent Process and Federal Regulations That Must Be Met to Waive Informed Consent Tracey Craddock Regulatory Compliance.
1 The HIPAA Privacy Rule and Research This presentation will probably involve audience discussion, which will create action items. Use PowerPoint to keep.
Content of Regulatory/Study Binder Human Subject Protection Office UConn Health Center Monika Haugstetter, MHA, RN, MSN & HSPO/IRB Staff.
RESEARCH COMPLIANCE Agenda 1. No Destruction of local research documents after scanning 2. Training for shipping biological samples/specimens 3. Regulatory.
Criteria For Approval 45 CFR CFR Minimized risks Reasonable risk/benefit ratio Equitable subject selection Informed consent process Informed.
Informed Consent.
UTHSC IRB Donna Hollaway, RN, CCRC 11/30/2011 Authority to Audit 45 CFR (e) An IRB shall conduct continuing review of research covered by this.
Informed Consent Waivers IRB Health Sciences & Behavioral Sciences University of Michigan /26/20091.
Protecting the Privacy of Family Members in Survey and Pedigree Research Jeffrey R. Botkin, MD, MPH University of Utah.
© HRP Associates, Inc. Informed Consent, Parental Permission & Assent Jeffrey M. Cohen, Ph.D., CIP President, HRP Associates, Inc.
Health Insurance Portability Accountability Act of 1996 HIPAA for Researchers: IRB Related Issues HSC USC IRB.
Institutional Review Boards (IRBs), Informed Consent, and Responsibilities Requirement for IRBs -DHHS: 45 CFR Part 46 -FDA: 21 CFR 56 Requirement for and.
ORO Findings on Privacy, Confidentiality, and Information Security Peter N. Poon, JD, MA, CIPP/G Office of Research Oversight Initially presented June.
1 Developed by: U-MIC To start the presentation, click on this button in the lower right corner of your screen. The presentation will begin after the.
IRB 101: Informed Consent Columbia University Medical Center IRB September 22, 2005.
CUMC IRB Investigator Meeting November 9, 2004 Research Use of Stored Data and Tissues.
8 Criteria for IRB Approval of Research 45 CFR (a)
Informed Consent and HIPAA Tim Noe Coordinating Center.
Human Investigation Committee  Is it research?  If yes, does it involve human subjects?  If yes, can it be exempt?  If no, will a Request for.
Health Insurance Portability and Accountability Act (HIPAA)
Is this Research? Exempt? Expedited?
Paula Peyrani, MD Medical/Project Director, HIV Program at the 550 Clinic Assistant Director, Research Design and Development Clinical and Translational.
1 NJ Dept. of Health Decision Tree for eIRB Submission Revised: 06/18/2015 Is this research defined as: A systematic investigation which includes research.
Using the Internet to Conduct Research What Investigators and IRB Members Should Know -- January 29, Lisa Shickle, MS Analyst, VCU Massey Cancer.
HRPP Training – Session Two Human Research Protection Program Manager
Institutional Review Board (IRB) Human Subject Dr. John N. Austin, Director and Ms. Renee S. Jones, Associate Director Delaware State University Office.
1 Defense Health Agency Privacy and Civil Liberties Office HIPAA Privacy Board Overview August 6, 2015.
Michelle Groy Johnson Quality Improvement Officer Research Integrity Office Tough Love: Understanding the Purpose and Processes of Quality Assurance.
IRB Board Education Session 6 How Consent Regulations are Implemented in INSPIR Mary Banks Director, Office of the IRB June -July 2005.
Confidentiality Issues in Research with Human Subjects Sarah Frankel, Ph.D. Human Studies Committee Washington University.
HIPAA and Research Basics for IRB Tim Atkinson Director, Research and Sponsored Programs Director, Institutional Review Board Research Privacy Officer.
NE SNIP PRIVACY WORKGROUP Use and Disclosure of Protected Health Information Regarding a Deceased Individual.
May I have your permission please? The consent process: What, Where, When, Who and Why Valerie Smith OHRP IRB Program Manager
Privacy and Confidentiality. Definitions n Privacy - having control over the extent, timing, and circumstances of sharing oneself (physically, behaviorally,
Expedited Review – Retrospective studies: A New Path Stephanie Gentilin, MA, CCRAKatherine Bright Director SCTR SUCCESS Center, eIRB Team MemberIRB, Grants.
Education Research and Social & Behavioral Science IRB.
AUDIT REQUIREMENTS, FINDINGS & BASICS RESEARCH COMPLIANCE.
Deception in Human Research Learning Objectives Define Deception and Incomplete Disclosure Understand when Deception or Incomplete Disclosure are allowable.
Health Insurance portability and Accountability Act (HIPAA)‏
A Road Map to Research at Jefferson: HIPAA Privacy and Security Rules for Researchers Presented By: Privacy Officer/Office of Legal Counsel October 2015.
HIPAA and Human Subjects Research IRB Member CE May 2014 Slideshow by Sean Horkheimer.
Case Studies: Puzzles in Human Research Kevin L. Nellis, M.S., M.T. (A.S.C.P.) Program Analyst, Program for Research Integrity Development and Education.
Regulatory requirements: children, assent, and consent waivers and waiver of documentation Bob Craig, 2007.
Informed Consent Process Patrick Herbison, MEd, CIP Research Compliance Manager Office of Human Research (OHR)
Avenues of Consent Options available under 45 CFR (d) &
Informed Consent Presented by Marian Serge, RN. Goals Informed consent process and form Title 38 CFR , Common Rule required elements and additional.
Informed Consent It’s a Process …not a form. Outline  Historical Background  Respect for Persons  Consent Process  Elements of Informed Consent 
Final HIPAA Privacy Rule: The Research Provisions Julie Kaneshiro DHHS Office for Human Research Protections Phone: Fax:
HIPAA and RESEARCH 5 th Thursday May 31, Page 2.
Slide 1 Standard Operating Procedures. Slide 2 Goal To review the standard operating procedures Creating the informed consent document Obtaining informed.
Informed Consent Betty Wilson, CIP, MS Senior Compliance Manager MU IRB Lori Wilcox, EdD Director of Academic Compliance, Corporate Compliance.
Instructions for New IRB Continuing Review (Progress) Report
Susan Sonne, PharmD, BCPP Chair, MUSC IRB II
The HIPAA Privacy Rule: Implications for Medical Research
Beverley Alberola, CIP Associate Director, Research Protections
Jamie Reddish, MPH Research Compliance Administrator
Dining with Diabetes IRB Training 2017.
Jeffrey M. Cohen, Ph.D. CIP President HRP Associates, Inc.
To start the presentation, click on this button in the lower right corner of your screen. The presentation will begin after the screen changes and you.
To start the presentation, click on this button in the lower right corner of your screen. The presentation will begin after the screen changes and you.
The HIPAA Privacy Rule and Research
This takes approximately 5 minutes or less from start to finish
Jeffrey M. Cohen, Ph.D. Associate Dean,
Appendix 2 of New Application
Revised Common Rule: Informed Consent Changes
Office of Research Integrity and Protections
Research with Human Subjects
Office of the Vice President for Research Human Subjects Protection Program IRB Submission Process Module 4 - Health Insurance Portability and Accountability.
Presentation transcript:

ICF & HIPAA waivers Human Subject Protection Office UConn Health Center Monika Haugstetter, MHA, RN, MSN & HSPO/IRB Staff

2 Waivers Partial waivers Request for Waiver of the Requirement to Consent Subject or Alteration of Consent Elements Request for Waiver of the Requirement to Document the Consent of Subjects Request for Waiver of HIPAA Authorization

3 General Guidelines Waiver not applicable in FDA regulated studies* Waiver not acceptable for convenience reasons Study must involve no more than minimal risk* * Note: There are rare exceptions to these guidelines

Request for Waiver of the Requirement to Consent Subject or Alteration of Consent Elements

5 Waiver to Consent Form 1. Indicate whether a waiver or alteration of consent is being requested –Partial Waiver Phone Screening/Recruitment –Full Waiver of Consent –Alteration of Consent Elements Description of alterations requested

6 Waiver to Consent Form 2. Will the research involve greater than minimal risk? ( Answer must be NO ) –Partial Waiver Solely to determine eligibility –Full Waiver of Consent Ex. Chart Reviews –Alteration to Consent Ex. Subjects initially intentionally misinformed for study purpose (not common)

7 Waiver to Consent Form 3. Could the research be practicably carried out without the waiver or alteration? ( Answer must be NO ) –Partial Waiver Ex. Impractical to require every caller to come for screening visit –Full Waiver of Consent Ex. Chart Review (volume/people moved away/time constraint)

8 Waiver to Consent Form 4. Will waiving/altering informed consent adversely affects subjects’ rights and welfare? ( Answer must be NO ) –Partial Waiver Right to not answer questions or end phone call Subjects fully consented if choose to participate Forms of screen failures consist no names/numbers –Full Waiver of Consent Confidentiality of data protected by codes, passwords, secured locations

9 Waiver to Consent Form 5. Will pertinent information be provided to subjects later? ( Yes/No ) –Partial Consent Informing person re meeting eligibility, full consenting visit, study requirements, etc. –Full Waiver of Consent If not possible, explain reasons (ex. contact information not part of data)

Request for Waiver of the Requirement to Document the Consent of Subjects

11 Waiver to Document Consent Build into IRB application (section 9) OR Use separate form Consent process still occurs Documentation waived

12 Waiver to Document Consent 1 st scenario: ICF only link between subject & research due to potential harm if breach of confidentiality Minimal risk criteria not applicable Not applicable in FDA studies ICF developed/IRB approved

13 Waiver to Document Consent 1 st scenario (cont): ICF (written documentation) as source of information No need to sign the ICF but subject has right to opt to do Examples –Ex. doing blood draws of HIV+ subjects –Ex. research involving women abused by spouses –Ex. research on drug use / sales

14 Waiver to Document Consent 2 nd scenario: No more than minimal risk of harm to subjects No procedures that would require written consent outside of research context IRB may require investigators to provide written summary –Ex. surveys/interviews

Request for Waiver of HIPAA Authorization

16 HIPAA Waiver Used in conjunction w/ waiver for consent Not practical to conduct research w/out waiver

17 HIPAA Waiver 1. Use/disclosure of PHI involves no more than minimal risk to subject privacy –Risks reasonable in relation to benefits –List specific PHI/their sources collected –Partial Waiver Recording of name & phone number only for eligible callers

18 HIPAA Waiver 2. Plan to protect identifiers –Describe storage –Describe in details access (PI, study personnel, FDA, other government agencies, DSMB, etc.) –Partial Waiver For ineligible persons, information shredded; for eligible persons (subjects), PHI maintained in secured/locked location

19 HIPAA Waiver 3. Procedures to destroy data collected during study –Destroyed at earliest opportunity consistent with study design/protocol –Ex. Records kept for 3 yrs after study conclusion on site, then hardcopy shredded/electronic data erased

20 HIPAA Waiver 4. Research not practicably conducted without waiver –Response similar to waiver of consent –Partial Waiver Solely requested for phone screening

21 HIPAA Waiver 5. Not practical to conduct research without access/use of PHI –Ex. Chart Review or Survey –Partial Waiver Preliminary view of PHI necessary to determine eligibility (ex. phone screening)

22 HIPAA Waiver 6. Why PHI obtained for this study is the minimum information needed to meet study objectives –Partial Waiver Only pertinent information (inclusion/exclusion) asked Name/phone number only for those eligible/ interested in enrollment

23 Infrequent Waivers If you ever need one of these: Request for Waiver of the Requirement to Consent Subject for Planned Emergency Research Request for Waiver of the Requirement to Consent Subject or to Make Alteration to the Elements of Consent for Projects Conducted by or Subject to the Approval of State or Local Government Officials Contact IRB staff!

24 Contact Information IRB support –Patty Gneiting (exempt/expedited) x4849 –Donna Horne (panel 2 & 3) x4851 –Pam Colwell (panel 1 & 3) x1019 –Marcy Chasse (outgoing approvals) x8729 HSPO –Deb Gibb x3054 –Judy Gaffney x7555 –Monika Haugstetter x8802